Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
601117.SS Stock Summary
Top 10 Correlated ETFs
601117.SS
In the News
601117.SS Financial details
Company Rating
Strong Buy
Market Cap
38.8B
Income
5.42B
Revenue
169.52B
Book val./share
-
Cash/share
-
Dividend
0.18
Dividend %
2.79%
Employees
46.71K
Optionable
No
Shortable
Yes
Earnings
27 Oct 2023
P/E
7.22
Forward P/E
5.34
PEG
-7.58
P/S
0.23
P/B
0.7
P/C
-
P/FCF
25.77
Quick Ratio
1.13
Current Ratio
1.22
Debt / Equity
0.25
LT Debt / Equity
0.18
-
-
EPS (TTM)
0.76
EPS next Y
1.19
EPS next Q
-
EPS this Y
5.95%
EPS next Y
56.54%
EPS next 5Y
82.46%
EPS last 5Y
17.94%
Revenue last 5Y
14.23%
Revenue Q/Q
-16.97%
EPS Q/Q
-
-
-
-
-
SMA20
-5.6%
SMA50
-14.68%
SMA100
-21.22%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
10%
ROC
0.09%
Gross Margin
10%
Oper. Margin
4%
Profit Margin
3%
Payout
29%
Shs Outstand
6.11B
Shs Float
2.18B
-
-
-
-
Target Price
-
52W Range
6.34-11.3
52W High
-42.27%
52W Low
+5.83%
RSI
24.61
Rel Volume
0.93
Avg Volume
43.11M
Volume
40.26M
Perf Week
-3.64%
Perf Month
-13.72%
Perf Quarter
-21.6%
Perf Half Y
-24.04%
-
-
-
-
Beta
0.706
-
-
Volatility
0.11%, 0.19%
Prev Close
-1.4%
Price
6.35
Change
-2.61%
601117.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.44 | 21.09 | 21.34 | 25 | 26.04 | |
Net income per share | 0.39 | 0.62 | 0.71 | 0.84 | 0.89 | |
Operating cash flow per share | 0.99 | 0.96 | 1.62 | 0.41 | 0.25 | |
Free cash flow per share | 0.79 | 0.8 | 1.45 | -0.29 | -0.25 | |
Cash per share | 5.69 | 6.6 | 7.6 | 8.25 | 7.1 | |
Book value per share | 6.63 | 7.12 | 7.31 | 8.74 | 8.69 | |
Tangible book value per share | 6.66 | 7.1 | 7.44 | 8.87 | 8.96 | |
Share holders equity per share | 6.63 | 7.12 | 7.31 | 8.74 | 8.69 | |
Interest debt per share | 1.17 | 1.4 | 1.29 | 1.46 | 1.4 | |
Market cap | 26.35B | 31.8B | 30.25B | 66.19B | 48.31B | |
Enterprise value | 3.62B | 6.11B | -2.39B | 29.69B | 14.45B | |
P/E ratio | 13.64 | 10.39 | 8.27 | 14.29 | 8.92 | |
Price to sales ratio | 0.32 | 0.31 | 0.28 | 0.48 | 0.3 | |
POCF ratio | 5.37 | 6.73 | 3.63 | 29.53 | 32.22 | |
PFCF ratio | 6.72 | 8.03 | 4.06 | -41.63 | -31.33 | |
P/B Ratio | 0.8 | 0.9 | 0.8 | 1.37 | 0.91 | |
PTB ratio | 0.8 | 0.9 | 0.8 | 1.37 | 0.91 | |
EV to sales | 0.04 | 0.06 | -0.02 | 0.22 | 0.09 | |
Enterprise value over EBITDA | 0.68 | 0.91 | -0.34 | 4.08 | 1.67 | |
EV to operating cash flow | 0.74 | 1.29 | -0.29 | 13.25 | 9.63 | |
EV to free cash flow | 0.92 | 1.54 | -0.32 | -18.67 | -9.37 | |
Earnings yield | 0.07 | 0.1 | 0.12 | 0.07 | 0.11 | |
Free cash flow yield | 0.15 | 0.12 | 0.25 | -0.02 | -0.03 | |
Debt to equity | 0.16 | 0.19 | 0.17 | 0.16 | 0.16 | |
Debt to assets | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 | |
Net debt to EBITDA | -4.24 | -3.82 | -4.7 | -5.02 | -3.92 | |
Current ratio | 1.39 | 1.25 | 1.21 | 1.18 | 1.19 | |
Interest coverage | 7.35 | 19.57 | 10.35 | 24.59 | 23.85 | |
Income quality | 2.36 | 1.44 | 2.17 | 0.45 | 0.26 | |
Dividend Yield | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | |
Payout ratio | 0.43 | 0.33 | 0.23 | 0.35 | 0.25 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.2 | -0.16 | -0.11 | -1.71 | -2.03 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | |
Capex to depreciation | -1.01 | -0.72 | -0.77 | -3.23 | -2.22 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.63 | 9.96 | 10.8 | 12.85 | 13.19 | |
ROIC | 0.05 | 0.11 | 0.09 | 0.08 | 0.09 | |
Return on tangible assets | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | |
Graham Net | -0.46 | -1.95 | -1.6 | -2.57 | -2.93 | |
Working capital | 21.3B | 17.73B | 18.15B | 21.5B | 23.6B | |
Tangible asset value | 33B | 35.05B | 38.33B | 48.93B | 54.5B | |
Net current asset value | 14.33B | 9.51B | 10.64B | 12.66B | 14.38B | |
Invested capital | 0.16 | 0.19 | 0.17 | 0.16 | 0.16 | |
Average receivables | 31.41B | 35.69B | 49.71B | 72.6B | 90.18B | |
Average payables | 28.14B | 34.22B | 45.43B | 57.86B | 66.56B | |
Average inventory | 14.74B | 14.09B | 9.39B | 4.71B | 5.71B | |
Days sales outstanding | 147.89 | 134.5 | 202.56 | 222.72 | 221.62 | |
Days payables outstanding | 151.91 | 151.8 | 196.04 | 185.84 | 178.02 | |
Days of inventory on hand | 68.94 | 57.5 | 15.72 | 15.31 | 15.79 | |
Receivables turnover | 2.47 | 2.71 | 1.8 | 1.64 | 1.65 | |
Payables turnover | 2.4 | 2.4 | 1.86 | 1.96 | 2.05 | |
Inventory turnover | 5.29 | 6.35 | 23.21 | 23.83 | 23.11 | |
ROE | 0.06 | 0.09 | 0.1 | 0.1 | 0.1 | |
Capex per share | -0.2 | -0.15 | -0.17 | -0.69 | -0.5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.44 | 6.17 | 6.93 | 7.87 | 0 | |
Net income per share | 0.18 | 0.28 | 0.18 | 0.3 | 0 | |
Operating cash flow per share | 0.18 | 0.28 | 0.18 | 1.01 | 0 | |
Free cash flow per share | 0.09 | 0.08 | 0.07 | 0.91 | 0 | |
Cash per share | 5.5 | 7.03 | 6.05 | 6.79 | 0 | |
Book value per share | 8.35 | 8.61 | 8.76 | 8.9 | 0 | |
Tangible book value per share | 8.38 | 8.88 | 9.02 | 9.21 | 0 | |
Share holders equity per share | 8.35 | 8.61 | 8.76 | 8.9 | 0 | |
Interest debt per share | 1.55 | 1.35 | 2.06 | 2.22 | 0 | |
Market cap | 48.92B | 48.75B | 57.27B | 51.1B | 0 | |
Enterprise value | 25.7B | 14.88B | 33.73B | 23.94B | -21.81B | |
P/E ratio | 11.42 | 7.19 | 12.89 | 6.96 | 0 | |
Price to sales ratio | 1.08 | 1.29 | 1.34 | 1.05 | 0 | |
POCF ratio | 45.66 | 28.76 | 51.56 | 8.18 | 0 | |
PFCF ratio | 91.11 | 102.26 | 130.29 | 9.09 | 0 | |
P/B Ratio | 0.96 | 0.92 | 1.06 | 0.93 | 0 | |
PTB ratio | 0.96 | 0.92 | 1.06 | 0.93 | 0 | |
EV to sales | 0.57 | 0.39 | 0.79 | 0.49 | -0.54 | |
Enterprise value over EBITDA | 16.84 | 6.21 | 21.7 | 9.29 | -20.12 | |
EV to operating cash flow | 23.99 | 8.78 | 30.36 | 3.83 | 6.07 | |
EV to free cash flow | 47.87 | 31.22 | 76.73 | 4.26 | 4.33 | |
Earnings yield | 0.02 | 0.03 | 0.02 | 0.04 | 0 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.11 | 0 | |
Debt to equity | 0.18 | 0.16 | 0.23 | 0.25 | 0.25 | |
Debt to assets | 0.05 | 0.04 | 0.06 | 0.06 | 0.07 | |
Net debt to EBITDA | -15.21 | -14.12 | -15.15 | -10.55 | -20.12 | |
Current ratio | 1.19 | 1.19 | 1.21 | 1.21 | 1.22 | |
Interest coverage | 13.86 | 26 | 16.89 | 24.96 | 10.37 | |
Income quality | 1 | 1 | 1 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0.02 | 0 | |
Payout ratio | 0.19 | 0.04 | 0.07 | 0.68 | 0.27 | |
Sales general and administrative to revenue | 0.03 | -0.03 | 0.02 | -0.01 | 0.04 | |
Research and developement to revenue | 0.03 | 0.06 | 0.02 | 0.03 | 0.04 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.5 | -0.72 | -0.6 | -0.1 | 0.4 | |
Capex to revenue | -0.01 | -0.03 | -0.02 | -0.01 | -0.04 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.74 | 7.32 | 5.96 | 7.72 | 0 | |
ROIC | 0.02 | 0.03 | 0.02 | 0.03 | 0.01 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Graham Net | -2.99 | -2.9 | -3.26 | -3.34 | 0 | |
Working capital | 23.12B | 23.6B | 26.37B | 29.31B | 30.82B | |
Tangible asset value | 51.15B | 54.5B | 55.65B | 56.82B | 57.55B | |
Net current asset value | 13.41B | 14.38B | 14.89B | 16.48B | 17.69B | |
Invested capital | 0.18 | 0.16 | 0.23 | 0.25 | 0.25 | |
Average receivables | 96.62B | 97.34B | 100.68B | 108.73B | 114.92B | |
Average payables | 68.13B | 70.23B | 72.19B | 79.59B | 84.23B | |
Average inventory | 6.99B | 6.67B | 6.59B | 6.75B | 6.82B | |
Days sales outstanding | 195.14 | 228.69 | 221.16 | 208.15 | 262.44 | |
Days payables outstanding | 151 | 194.74 | 171.08 | 172.38 | 204.35 | |
Days of inventory on hand | 15.25 | 17.28 | 16.02 | 13.28 | 17.33 | |
Receivables turnover | 0.46 | 0.39 | 0.41 | 0.43 | 0.34 | |
Payables turnover | 0.6 | 0.46 | 0.53 | 0.52 | 0.44 | |
Inventory turnover | 5.9 | 5.21 | 5.62 | 6.78 | 5.19 | |
ROE | 0.02 | 0.03 | 0.02 | 0.03 | 0.01 | |
Capex per share | -0.09 | -0.2 | -0.11 | -0.1 | 0 |
601117.SS Frequently Asked Questions
What is China National Chemical Engineering Co., Ltd stock symbol ?
China National Chemical Engineering Co., Ltd is a CN stock and trading under the symbol 601117.SS
What is China National Chemical Engineering Co., Ltd stock quote today ?
China National Chemical Engineering Co., Ltd stock price is $6.35 today.
Is China National Chemical Engineering Co., Ltd stock public?
Yes, China National Chemical Engineering Co., Ltd is a publicly traded company.